About Simomics

Based in York since 2014, Simomics is an ethics-led software technology company, driven by a strong mission and purpose to promote corporate environmental responsibility in the chemical industries (pharmaceuticals, personal care products, agrochemicals and more).

Our solutions predict, calculate, and demonstrate the environmental impact of chemicals with scientific confidence and clarity. Our focus is on providing the chemical industries the tools to be proactive, accurate and transparent in their environmental protection initiatives.

Our values

Rooted in science

We’re committed to the highest standards of evidence-based decision making. We are accountable, honest, and responsible.


We create accelerated change. We enable open discussion, actively listen, and seek proactive collaboration.


We’re creating a culture that thrives on improving, learning, and evolving to drive essential change.


We’re powered by knowledgeable people who make things happen to raise the standard across the industry.


Our board members

Angus Jackson OBE


Angus is a business leader with experience gained across a range of industries. He has worked in both the public and private sectors, in the UK and internationally. Angus leads our commercial activities and is responsible for growing the company.

Prof Mark Coles


Mark is an immunologist and an expert in computational immunology with a focus on development of therapeutics for cancer and inflammatory disease. He is Kennedy Professor of Immunology at University of Oxford, Senior Research Fellow and Director of Graduate Studies at the Kennedy Institute of Rheumatology and Official Fellow and Theme Lead for Cellular Life at Reuben College, at the University of Oxford.

Prof Jon Timmis


Jon is an engineer with over 20 years’ experience of computational modelling, software design and interdisciplinary working. He is a former Royal Society-Wolfson Research Merit Award holder and a former Royal Academy of Engineering Enterprise Fellow. Jon is now Deputy Vice-Chancellor at the University of Sunderland.

Prof Vipin Kumar


Vipin is an immunologist and an expert in immune regulation mediated by regulatory T-cells and NKT-cells in the control of autoimmunity and inflammation. Vipin is also co-founder of GRI a company developing NKT cell-based therapies. Vipin is based at UCSD, in San Diego, USA.

Toby Jackson


Toby is a venture capitalist with experience in advanced engineering technologies.

Our team

Our leadership

Dr Ian Barwick


Ian is a scientist and commercial director with over 20 years’ experience in senior roles within private and public life science organisations. Throughout his career, he has focused on innovation and its successful delivery within the pharmaceutical, medtech and healthcare sectors.

Grainne Timmis


Grainne has a science and business background with over 20 years’ experience working in IT consultancy and agile software development.

Scroll to Top